EFFECT OF REMOGLIFLOZIN ON BIOMARKERS COMPARED TO EMPAGLIFLOZIN INPATIENTS OF TYPE 2 DIABETES MELLITUS WITH CHRONIC HEART FAILURE (REMIT HF)

Autor: Sengupta, Shantanu, Jayagopal, Pathiyal B., Sawhney, Jitendra Pal Singh, mehta, ashwani, Suryavanshi, Satish Chainsingh, Jamwal, Naveen, Gowda, Dr Ambanna, Dargad, Ramesh Ratanlal, Kapoor, Vinod, Bhushan, Sumit, Gadkari, Rujuta, BARKATE, HANMANT, BHATE, AMIT SURESH, Patil, Saiprasad
Zdroj: In Journal of the American College of Cardiology 2 April 2024 83(13) Supplement:549-549
Databáze: ScienceDirect